February 2016 Newsletter
Access JTO Online
We are pleased to offer all issues of the Journal of Thoracic Oncology online back to Volume 1, Issue 1 (2006) for desktop or mobile reading. Access to abstracts and articles more than one year old is complimentary. Full articles for the current year are available to IASLC members.
IASLC members have two options:
Deadline: Feb. 15 - Membership Feedback Requested
Chance to win an iPad when you complete the IASLC 2015 Membership Survey
The deadline for the survey is Feb. 15, 2016. Responding automatically enters you into a random drawing to win an Apple iPad.
Please note the survey link was emailed individually to all members, and will be anonymous, unless you provide your contact details during the survey. If you did not receive the survey in your email inbox, please contact firstname.lastname@example.org.
The anonymous survey will take members no longer than 5 minutes to complete. Thank you for your feedback!
Lung Cancer Survivor Earns Trip to Pro Bowl
Lung cancer survivor Kathy Weber attained second place in Team Draft’s 2016 Lung Cancer Survivors Super Bowl Challenge, raising more than $8,000 on behalf of the IASLC Foundation. Reaching the number two spot means Kathy and her family took a trip to the NFL Pro Bowl in Hawaii on Jan. 31, 2016. Watch her thank you video from Hawaii.
In the picture on the right, Kathy (left) stands next to former NFL linebacker Chris Draft, lung cancer survivor Kim Ringen, DVM, and Kim's husband Davin. Kim earned first place in the contest so she and Davin will head to San Francisco to attend the Super Bowl in early February.
Team Draft's Super Bowl Challenge recruits lung cancer survivors to raise funds to help find new ways to combat the disease. Even though Team Draft selected the winners, Kathy and the other lung cancer survivors can still raise money until Feb. 7, 2016. Learn more and donate.
Kathy's donation is one of several to benefit the IASLC Foundation over the past few weeks. Learn more.
International Funding Opportunities
As a service to our members we post funding opportunities related to lung cancer and other thoracic malignancies on our website when we receive information from grantors.
We currently have four opportunities posted:
These opportunities are available to applicants from all countries. Click here to learn more.
Social Media Corner: Using Social Media Within the Lung Cancer Community
By Anne-Marie Baird, PhD
We are starting a new feature to help our members understand and better use social media. An increasing number of lung cancer patients, caregivers, advocates, researchers and medical professionals connect through social media platforms such as blogs, forums, Twitter and Facebook.
Central to Twitter is the use of hashtags (the # symbol in front of a word), which allows people to search by topic. The lung cancer community frequently uses #LCSM (Lung Cancer Social Media). #LCSM also has its own blog (http://lcsmchat.com) with links to lung cancer resources, information on upcoming Tweetchats and chat transcripts. The use of official conference hashtags are important within #LCSM, as they increase exposure and build the community. Check out: http://www.symplur.com/healthcare-hashtags/wclc2015/ for analytics and transcripts related to #WCLC2015.
If you want to share information about your #research; #publications; #conferences; #ClinicalTrials; #funding or anything else the lung community may find helpful, please include #LCSM in your posts. Learn more about the use of social media in oncology at http://jop.ascopubs.org/content/8/5/e114.full.
February 2016: The International Association for the Study of Lung Cancer (IASLC) and the Journal of Thoracic Oncology (JTO) are pleased to present the Editor's Choice each month to highlight certain articles of interest. The selected articles each month will be made available to the public for a limited time upon printing. The articles below from the February issue of JTO are free for three months. Please share with your colleagues around the globe!
Alex A. Adjei, MD, PhD
The World Health Organization Classification of Tumors is a global standard for tumor diagnosis. To make these classifications current and relevant to the state of the science, they are periodically updated. The 2015 WHO Classification of Tumors of the Lung, Pleura, Thymus and Heart was just published. Based on the leadership role taken by the IASLC pathology committee in this work, the JTO is publishing a series of articles summarizing key points about the new classification, and outlining the major changes from the 2004 classification. The second in this series by Travis et al is highlighted this month.
In the second highlighted manuscript, Silva et al present provocative data in their study. Dr Murray and colleagues have written a very thoughtful editorial to accompany this work.
Predicting Radiation Esophagitis Using 18F-FDG PET During Chemo-Radiotherapy For Locally Advanced Non-Small Cell Lung Cancer
The final selection highlights the interesting work by Dr. Sun and colleagues who outline approaches to predicting radiation esophagitis.
The following articles have been selected by the IASLC Communications Committee from the JTO to be promoted to the media and the public with press releases that were released at the time of online publication (Published Ahead of Print). To read more IASLC Press Releases, please visit IASLC Research Articles. These press releases are also announced via social media, so please follow IASLC on Twitter and Facebook to stay up to date on the latest scientific topics!
The requirement for tumor tissue specimens and associated analyses in order to participate in clinical trials appears to be a significant barrier to clinical trial enrollment and may delay treatment. Potential solutions to reducing or eliminating these barriers include routine tissue banking at diagnosis, easing use of available diagnostic samples, development of less invasive tests, faster turnaround time at central laboratories or allowing for local testing and more resources for timely tissue collection.
Jan. 4, 2016 | More
An increase in the stage of non-small cell lung cancer (NSCLC) due to cancer positive lymph node (LN) discovery was more common following open chest surgery for lung lobe removal of early stage lung cancer compared to the closed chest procedure known as video assisted thoracic surgery (VATS).
Jan. 11, 2016 | More
IASLC now has 175 members in the UK and Ireland – making the UK the 6th largest country of IASLC membership. In 2015, IASLC introduced two special membership offers for members of BTOG ($125 for 1-year and $475 for 3-year membership), and Nursing members of the National Lung Cancer Forum for Nurses (NCLFN) to receive a discounted introductory membership offer ($30 for 1-year membership). For more details about this special offer, please visit https://www.iaslc.org/btog-membership-offer.
BTOG is a UK lung cancer and mesothelioma research group. BTOG aims to improve the care of patients with thoracic malignancies through multidisciplinary education, developing and advising on guidelines for patient care and facilitating and nurturing clinical trial ideas into full protocols.
BTOG represents all disciplines involved in the care of lung cancer and mesothelioma throughout the UK, including medical and clinical oncologists, respiratory physicians, surgeons, radiotherapists, radiologists, nurses, pharmacists and scientists. All individuals involved in any aspect of lung cancer or mesothelioma research, care or treatment are eligible to become members of the group.
The 2016 BTOG Annual Meeting was once again endorsed by the IASLC Education Committee. Attendance increased to 775, with 190 posters presented. BTOG was pleased to invite several IASLC Board members to participate, including IASLC CEO, Fred R. Hirsch (Biomarkers for immune-checkpoint therapies), IASLC President, David Carbone (Genomic-led trial designs for lung cancer), Board Member Professor Keith Kerr (2015 IASLC/ WHO Pathological classification), and IASLC Past Presidents Peter Goldstraw (8th Edition IASLC Lung Staging System) and Dr. Frances Shepherd (Will immunotherapy replace chemotherapy?). In addition, many other IASLC members and Committee members from the UK also presented topics. The conference is truly multidisciplinary, offering dedicated symposia for radiotherapy planning, pulmonology and thoracic radiology, as well as ‘whole team’ sessions, and more formal collaborative sessions with the British Thoracic Society and the Society for Cardiothoracic Surgery. The 14th BTOG Conference was able to showcase the UK thoracic oncology research portfolio by hosting the NCRI/NLCFN workshops for debate.
Welcome New Members - Invite Colleagues!
COMPLIMENTARY Fellows/Residents/Students/Trainees Membership – Group Program Registration
Welcome New IASLC Members through January 29, 2016 (listed by country, then name):
IASLC Foundation Benefits from Lung Cancer Survivors and Advocates
Lauren recently gave the IASLC Foundation a donation of $25,600 in John's memory. We pledge to do whatever we can to honor John's legacy as we strive to find new groundbreaking treatments for those facing the battle with thoracic cancers. Learn more.
Pikes Peak Browns Backers
To honor her battle with lung cancer, Pikes Peak Browns Backers gave $1,000 to the IASLC Foundation as part of its annual charity donation during the final game of the regular NFL season.
Doctors diagnosed Lisa with Stage IV NSCLC in August 2015. While surgery is not currently an option for Lisa, she’s undergone radiation treatments and is taking an EGFR inhibitor. Learn more.
New Book, "When Breath Becomes Air," Focuses on Lung Cancer
Become a Member
Join the only international association solely dedicated to lung cancer research and treatment.
WCLC Virtual Library
September 23 - 26 2018Toronto, Canada
November 8 - 10 2018Guangzhou, China
February 20 - 23 2019Santa Monica, California